Bulgaria vs Morocco: Cause of death, by non-communicable diseases, female
Bulgaria
78.1%
in 2021
Morocco
78.7%
in 2021
Bulgaria rank
51st
Morocco rank
48th
Cause of death, by non-communicable diseases, female over time
- Bulgaria
- Morocco
How they compare
Morocco currently reports 78.7% against 78.1% in Bulgaria, a difference of 0.6%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Bulgaria ahead.
Bulgaria ranks 51st and Morocco ranks 48th of 185 countries.
Bulgaria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bulgaria | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 95.0% | 67.9% | 27.1% | Bulgaria |
| 2010s | 96.8% | 84.4% | 12.3% | Bulgaria |
| 2020s | 84.3% | 78.7% | 5.6% | Bulgaria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Bulgaria or Morocco?
- Morocco, at 78.7% against 78.1% in Bulgaria as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Bulgaria and Morocco?
- 0.6%, with Morocco ahead.
- How many years of comparable data are there for Bulgaria and Morocco?
- 6 years are reported by both, from 2000 to 2021.
- How do Bulgaria and Morocco rank globally for cause of death, by non-communicable diseases, female?
- Bulgaria ranks 51st and Morocco ranks 48th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.